Fangda Partners, Healthcare (PRC Firms) | Chambers Greater China Region Profile

About

Provided by Fangda Partners

We are one of the few law firms in China that has a dedicated team in the pharmaceutical, biotechnology and healthcare sector. We provide the full range of commercial legal services to pharma, biotechnology, medical devices and other healthcare businesses.

Our experience in this sector covers traditional M&A, product-related transactions, research and development, new product launch, in-license and out-license, private equity and venture capital investment, domestic and overseas capital markets, regulatory and compliance advices, data protection and vertical and horizontal monopoly arrangements.

Our clients range from large and medium-sized pharmaceutical companies, innovative pharmaceutical firms, medical device companies, professional sales organizations, CROs, hospitals and industry associations to private equity funds and venture capital businesses. We advise companies headquartered in the U.S., Europe, China and across Asia.

We are set up in such a way to offer clients a seamless service across offices and practice areas. We provide integrated teams drawn from different legal disciplines to cover every angle of a deal. We recognize the importance of identifying early the key legal issues and planning a strategy to ensure the most effective management of any transaction on which we are retained. One team, one solution is our practiced method of working.

Chambers Review

Provided by Chambers

Healthcare (PRC Firms) - China

Band 2

What the Team is Known For

The respected life sciences and healthcare team at Fangda Partners has a strong track record in a variety of transactions and contentious issues. Fangda is a well-known full-service firm advising both international and local clients on the healthcare industry. Its clients include high-profile pharmaceutical and biotech companies, private equity firms and blue-chip medical device companies. Leveraging the firm's wider expertise, the team is well experienced in handling IP, M&A, capital markets and regulatory compliance as well as government investigation and enforcement matters.

业务优势

方达律师事务所受尊敬的生命科学和医疗保健团队在各种医疗保健相关的交易和争议性事宜上展现出色的过往业绩。该团队十分知名，提供全面服务，在医事领域为本地和国际客户提供咨询服务。客户包括著名制药和生物技术公司、私募股权公司和蓝筹医疗设备公司。该团队运用所内更广泛的其他方面专业知识，在处理知识产权、并购、合规监管和政府执法事宜上经验丰富。

View ranking table

Work Highlights

Provided by Fangda Partners

Fangda Partners represented AnHeart Therapeutics, a global clinical-stage biopharmaceutical company, on its full acquisition by the NYSE-listed company Nuvation Bio.
方达律师事务所代表全球性的临床阶段生物制药公司葆元医药，就其以全股票交易方式被一家纽交所上市公司Nuvation Bio完全收购提供法律服务。

Strengths

Provided by Chambers

Fangda is a one-stop shop for all legal needs with top talents from different specialities and yet working very closely as a team.